PIK3CA testing and treatment patterns among patients with metastatic breast cancer in US community clinical practice

被引：0
|
作者：
Kim, Eunice
Dhillon, Preet Kaur
Lambert, Peter
Cheng, Anna
Basho, Reva K.
机构：
[1] Genentech Inc, San Francisco, CA USA
[2] Ellison Inst Technol, Los Angeles, CA USA
来源：
JOURNAL OF CLINICAL ONCOLOGY | 2024年 / 42卷 / 16期
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
e13059
引用
收藏
页数：1
相关论文
共 50 条
  • [1] A real-world assessment of PIK3CA testing and alpelisib treatment patterns among metastatic breast cancer patients in a community oncology setting
    O'Shaughnessy, Joyce
    Paulson, Steven
    Brisbin, Lorraine
    Lindsey, James
    Williford, Anna
    Lisi, Monica
    Parikh, Rohan C.
    Simmons, Stacey
    Balu, Sanjeev
    CANCER RESEARCH, 2022, 82 (04)
  • [2] PIK3CA alterations in metastatic breast cancer (mBC)
    Albanell, J.
    Casadevall, D.
    Sokol, E. S.
    Albacker, L. A.
    Elvin, J. A.
    Vergilio, J-A.
    Killian, J. K.
    Ngo, N.
    Lin, D.
    Ramkissoon, S.
    Severson, E.
    Ali, S. M.
    Schrock, A. B.
    Chung, J.
    Reddy, P.
    Miller, V. A.
    Alexander, B. M.
    McGregor, K.
    Ross, J. S.
    Leyland-Jones, B.
    ANNALS OF ONCOLOGY, 2019, 30 : 104 - +
  • [3] Implementation of PIK3CA biomarker testing for breast cancer patients targeted therapy: evidence for best practice
    Prekete, Niki
    Michelli, Maria
    Roupou, Eirini
    Chatziandreou, Ilenia
    Zougros, Alexandros
    Kaparis, Theofilos
    Kavantzas, Nikolaos
    Saetta, Angelica A.
    EUROPEAN JOURNAL OF HUMAN GENETICS, 2024, 32 : 261 - 261
  • [4] Testing patterns and prevalence of PIK3CA, AKT1, and PTEN alterations among patients (pts) with HR+/HER2-metastatic breast cancer (mBC) in the US
    Park, Leah
    Thompson, Samantha L.
    Roose, James
    Lu, Yichen
    Chaki, Moumita
    Lam, Clara
    Iorgulescu, Bryan
    JOURNAL OF CLINICAL ONCOLOGY, 2024, 42 (16)
  • [5] Natural history and outcome of patients presenting a metastatic breast cancer with PIK3CA mutation
    Mosele, Fernanda
    Verret, Benjamin
    Lusque, Amelie
    Filleron, Thomas
    Bachelot, Thomas
    Arnedos, Monica
    Campone, Mario
    Dalenc, Florence
    Lefeuvre, Claudia
    Sablin, Marie Paule
    Bonnefoi, Herve
    Lacroix, Ludovic
    Bieche, Ivan
    Goncalves, Anthony
    Jacot, William
    Jimenez, Marta
    Jacquet, Amelie
    Andre, Fabrice
    Andre, Fabrice
    CANCER RESEARCH, 2019, 79 (13)
  • [6] Molecular pathology of breast cancer: PIK3CA testing in the routine laboratory
    Falk, M.
    Schatz, S.
    Schmidt, S.
    Strohkamp, S.
    Tiemann, K.
    ONCOLOGY RESEARCH AND TREATMENT, 2021, 44 : 241 - 242
  • [7] PIK3CA mutation profiling in Vietnamese patients with breast cancer
    Vuong, Linh Dieu
    Ta, To Van
    Chu, Ha Hoang
    Truong, Van-Long
    Nguyen, Quang Ngoc
    META GENE, 2020, 25
  • [8] PIK3CA Mutation Assessment in HR+/HER2-Metastatic Breast Cancer: Overview for Oncology Clinical Practice
    Criscitiello, Carmen
    Marra, Antonio
    Curigliano, Giuseppe
    JOURNAL OF MOLECULAR PATHOLOGY, 2021, 2 (01): : 42 - 54
  • [9] Initiating breast cancer by PIK3CA mutation
    Miller, Todd W.
    BREAST CANCER RESEARCH, 2012, 14 (01):
  • [10] Initiating breast cancer by PIK3CA mutation
    Todd W Miller
    Breast Cancer Research, 14
12345